173 related articles for article (PubMed ID: 16557206)
21. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
22. Cancer screening with FDG-PET.
Ide M
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):23-7. PubMed ID: 16557201
[TBL] [Abstract][Full Text] [Related]
23. Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
Zhang H; Tian M; Oriuchi N; Higuchi T; Tanada S; Endo K
Eur J Radiol; 2003 Sep; 47(3):199-205. PubMed ID: 12927663
[TBL] [Abstract][Full Text] [Related]
24. PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study.
Scott AM; Gunawardana DH; Kelley B; Stuckey JG; Byrne AJ; Ramshaw JE; Fulham MJ
J Nucl Med; 2008 Sep; 49(9):1451-7. PubMed ID: 18703607
[TBL] [Abstract][Full Text] [Related]
25. Early clinical experience and impact of 18F-FDG PET.
Gutte H; Højgaard L; Kjaer A
Nucl Med Commun; 2005 Nov; 26(11):989-94. PubMed ID: 16208177
[TBL] [Abstract][Full Text] [Related]
26. Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study.
Pepe G; Rossetti C; Sironi S; Landoni C; Gianolli L; Pastorino U; Zannini P; Mezzetti M; Grimaldi A; Galli L; Messa C; Fazio F
Nucl Med Commun; 2005 Sep; 26(9):831-7. PubMed ID: 16096588
[TBL] [Abstract][Full Text] [Related]
27. Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection.
Zimny M; Kaiser HJ; Cremerius U; Reinartz P; Schreckenberger M; Sabri O; Buell U
Eur J Nucl Med; 1999 Aug; 26(8):818-23. PubMed ID: 10436193
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
[TBL] [Abstract][Full Text] [Related]
29. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
[TBL] [Abstract][Full Text] [Related]
30. Clear-PEM: a dedicated PET camera for improved breast cancer detection.
Abreu MC; Almeida P; Balau F; Ferreira NC; Fetal S; Fraga F; Martins M; Matela N; Moura R; Ortigão C; Peralta L; Rato P; Ribeiro R; Rodrigues P; Santos AI; Trindade A; Varela J
Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):208-10. PubMed ID: 16604628
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
32. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
Tatsumi M; Yutani K; Watanabe Y; Miyoshi S; Tomiyama N; Johkoh T; Kusuoka H; Nakamura H; Nishimura T
J Nucl Med; 1999 Apr; 40(4):566-73. PubMed ID: 10210214
[TBL] [Abstract][Full Text] [Related]
34. The clinical value of 18F-FDG detection with a dual-head coincidence camera: a review.
Ak I; Blokland JA; Pauwels EK; Stokkel MP
Eur J Nucl Med; 2001 Jun; 28(6):763-78. PubMed ID: 11440038
[TBL] [Abstract][Full Text] [Related]
35. The role of gamma-PET in the evaluation of patients with recurrent squamous cell cancer of the head and neck.
Goshen E; Yahalom R; Talmi YP; Rotenberg G; Oksman Y; Zwas ST
Int J Oral Maxillofac Surg; 2005 Jun; 34(4):386-90. PubMed ID: 16053847
[TBL] [Abstract][Full Text] [Related]
36. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
37. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
38. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
39. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy.
Dizendorf EV; Baumert BG; von Schulthess GK; Lütolf UM; Steinert HC
J Nucl Med; 2003 Jan; 44(1):24-9. PubMed ID: 12515872
[TBL] [Abstract][Full Text] [Related]
40. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
